Want to learn about how the latest developments in Pre-Exposure Prophylaxis (PrEP) can help health centers improve access to preventative care? Join NACHC for an in-depth discussion about the growing use of generics, the recent approval of a new long-acting injectable product, and updates to the CDC clinical guidelines. The featured speakers will also discuss the growing inequities in PrEP delivery and financing that must be addressed and provide an overview of federal policy options being considered to increase access to PrEP.
Featured Speakers
Amy Killelea, JD
Killelea Consulting
Josh Sharfstein, MD
Professor of the Practice of Health Policy and Management
